MYC copy number gains are associated with poor outcome in penile squamous cell carcinoma

Journal of Urology

Volumn 188, Issue 5, 2012, Pages 1965-1971

  Masferrer, Emili ^a,c   Ferrándiz Pulido, Carla ^b   Lloveras, Belén ^d   Masferrer Niubò, Magalí ^f   Espinet, Blanca ^e   Salido, Marta ^e   Rodríguez Rivera, María ^e   Alemany, Laia ^g,i   Placer, Jose ^b   Gelabert, Antoni ^j   Servitje, Octavi ^h   García Patos, Vicenç ^a   Pujol, Ramon M ^a   Toll, Agustí ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Hospitals Universitaris Vall d'H   (Spain)

^e Laboratori de Citogenètica Mollecular   (Spain)

^f UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^j HOSPITAL DEL MAR   (Spain)

more..

Author keywords

carcinoma; genes; human; human papillomavirus 16; myc; MYC protein; penis; squamous cell

Indexed keywords

MYC PROTEIN;

ADULT; ARTICLE; CARCINOGENESIS; CYTOGENETICS; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PENILE NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84867405559     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.07.003     Document Type: Article

References (30)

1. E. Stankiewicz, D.M. Prowse, E. Ktori The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma Histopathology 58 2011 433
2. J.R. Daling, M.M. Madeleine, L.G. Johnson Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease Int J Cancer 116 2005 606
3. M.C. Bleeker, D.A. Heideman, P.J. Snijders Penile cancer: epidemiology, pathogenesis and prevention World J Urol 27 2009 141
4. A.P. Lont, B.K. Kroon, S. Horenblas Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival Int J Cancer 119 2006 1078
5. A. Pascual, M. Pariente, J.M. Godinez High prevalence of human papillomavirus 16 in penile carcinoma Histol Histopathol 22 2007 177
6. H. De Vuyst, G.M. Clifford, M.C. Nascimento Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis Int J Cancer 124 2009 1626
7. C.L. Trimble, A. Hildesheim, L.A. Brinton Heterogeneous etiology of squamous carcinoma of the vulva Obstet Gynecol 87 1996 59
8. E. Stankiewicz, D.M. Prowse, M. Ng Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas PLoS One 6 2011 e17517
9. G. Alves, A. Heller, W. Fiedler Genetic imbalances in 26 cases of penile squamous cell carcinoma Genes Chromosomes Cancer 31 2001 48
10. S. Pelengaris, T. Littlewood, M. Khan Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion Mol Cell 3 1999 565
11. A. Toll, R. Salgado, M. Yebenes MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma Br J Dermatol 161 2009 1112
12. G. Martin-Ezquerra, R. Salgado, A. Toll Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours Br J Dermatol 163 2010 1028
13. M. Macville, E. Schrock, H. Padilla-Nash Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping Cancer Res 59 1999 141
14. A.A. Brink, J.C. Wiegant, K. Szuhai Simultaneous mapping of human papillomavirus integration sites and molecular karyotyping in short-term cultures of cervical carcinomas by using 49-color combined binary ratio labeling fluorescence in situ hybridization Cancer Genet Cytogenet 134 2002 145
15. M. Peter, C. Rosty, J. Couturier MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors Oncogene 25 2006 5985
16. B. Kleter, L.J. van Doorn, L. Schrauwen Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus J Clin Microbiol 37 1999 2508
17. J. Kononen, L. Bubendorf, A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844
18. M. Varella-Garcia Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay Diagn Pathol 1 2006 19
19. C.V. Dang c-Myc target genes involved in cell growth, apoptosis, and metabolism Mol Cell Biol 19 1999 1
20. D.J. Liao, R.B. Dickson c-Myc in breast cancer Endocr Relat Cancer 7 2000 143
21. S.L. Deming, S.J. Nass, R.B. Dickson C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance Br J Cancer 83 2000 1688
22. K. Joensuu, J. Hagström, M. Leidenius Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases - elevated Bmi-1 expression in late breast cancer relapses Virchows Arch 459 2011 31
23. X. Wu, Z.D. Cai, L.M. Lou Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients Cancer Epidemiol 36 2012 212
24. R. Berardi, A. Santinelli, A. Brunelli Epidermal growth factor receptor status in stages of resected non-small cell lung cancer: implications for treatment with epidermal growth factor receptor inhibitors Anal Quant Cytol Histol 33 2011 196
25. F. Sircoulomb, I. Bekhouche, P. Finetti Genome profiling of ERBB2-amplified breast cancers BMC Cancer 10 2010 539
26. L. Soucek, S. Nasi, G.I. Evan Omomyc expression in skin prevents Myc-induced papillomatosis Cell Death Differ 11 2004 1038
27. M. Savino, D. Annibali, N. Carucci The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy PLoS One 6 2011 e22284
28. R. Faridi, A. Zahra, K. Khan Oncogenic potential of human papillomavirus (HPV) and its relation with cervical cancer Virol J 8 2011 269
29. M.L. Tornesello, M.L. Duraturo, S. Losito Human papillomavirus genotypes and HPV16 variants in penile carcinoma Int J Cancer 122 2008 132
30. R. Samir, A. Asplund, T. Tot High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a J Low Genit Tract Dis 15 2011 280